Scodari Joseph C

Executive Committee Member at JOHNSON & JOHNSON · on record since Feb 22, 2006
Director at ENDO HEALTH SOLUTIONS INC. · on record since Aug 4, 2008
Retired Exec Committee Member at JOHNSON & JOHNSON · on record since May 30, 2008
Director at COVANCE INC · on record since May 20, 2008
Director at Acurx Pharmaceuticals, Inc. · on record since Apr 22, 2026
Director at OptiNose, Inc. · on record since Oct 16, 2017

Insider trading activity of Scodari Joseph C

Transactions on record: 130; since Feb 15, 2006

Open-market buys: 11; $360.5K

Open-market sells: 12; $8.2M

Companies traded: 5; last filing Apr 22, 2026

Figures computed from official regulatory filings — .

Companies where Scodari Joseph C has traded

Acurx Pharmaceuticals, Inc.6 tx · $25.1K · Apr 22, 2026
OptiNose, Inc.12 tx · $682.1K · Jun 9, 2022
COVANCE INC38 tx · $585.3K · Feb 23, 2015
ENDO HEALTH SOLUTIONS INC.36 tx · $49.5K · Mar 14, 2013
JOHNSON & JOHNSON38 tx · $14.9M · May 30, 2008

Track record of Scodari Joseph C

Statistical track record

Free account

Open-market buys: 12

Last buy: Jan 6, 2025

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Scodari Joseph C

Co-insiders of Scodari Joseph C

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Acurx Pharmaceuticals, Inc.Listing on record	Apr 22, 2026	AwardD (derivative)	2,150	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Acurx Pharmaceuticals, Inc.Listing on record	Jan 8, 2025	Buy	24,631	1.02 USD	$25.1K	conv 73ClusterFirst in 12mo	SEC
Acurx Pharmaceuticals, Inc.Listing on record	Jan 8, 2025	BuyD (derivative)	24,631	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	ClusterFirst in 12mo	SEC
Acurx Pharmaceuticals, Inc.Listing on record	Jun 18, 2024	AwardD (derivative)	12,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Acurx Pharmaceuticals, Inc.Listing on record	Jun 16, 2023	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptiNose, Inc.Listing unverified	Jun 9, 2022	AwardD (derivative)	32,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Acurx Pharmaceuticals, Inc.Listing on record	Jul 6, 2021	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptiNose, Inc.Listing unverified	Jun 10, 2021	AwardD (derivative)	14,439	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptiNose, Inc.Listing unverified	May 11, 2021	Buy	10,000	2.99 USD	$29.9K	conv 44First in 12mo	SEC
OptiNose, Inc.Listing unverified	Jun 12, 2020	AwardD (derivative)	14,439	5.65 USD	$81.6K		SEC
OptiNose, Inc.Listing unverified	Mar 9, 2020	Buy	200	5.53 USD	$1.1K	conv 16Unusual size	SEC
OptiNose, Inc.Listing unverified	Mar 9, 2020	Buy	2,000	5.56 USD	$11.1K	conv 20Unusual size	SEC
OptiNose, Inc.Listing unverified	Mar 9, 2020	Buy	6,500	5.75 USD	$37.4K	conv 34	SEC
OptiNose, Inc.Listing unverified	Dec 9, 2019	Buy	6,100	8.22 USD	$50.1K	conv 54	SEC
OptiNose, Inc.Listing unverified	Jun 10, 2019	AwardD (derivative)	14,439	6.60 USD	$95.3K		SEC
OptiNose, Inc.Listing unverified	Dec 12, 2018	Buy	6,430	7.89 USD	$50.7K	conv 48First in 12mo	SEC
OptiNose, Inc.Listing unverified	Jun 11, 2018	AwardD (derivative)	14,439	22.50 USD	$324.9K		SEC
OptiNose, Inc.Listing unverified	Oct 16, 2017	AwardD (derivative)	43,318	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
COVANCE INCListing unverified	Feb 23, 2015	Other	-7,466	—	n/a (No price was disclosed in the filing)		SEC
COVANCE INCListing unverified	Feb 23, 2015	OtherD (derivative)	-2,800	—	n/a (No price was disclosed in the filing)		SEC
COVANCE INCListing unverified	Feb 23, 2015	OtherD (derivative)	-1,700	—	n/a (No price was disclosed in the filing)		SEC
COVANCE INCListing unverified	Feb 23, 2015	OtherD (derivative)	-2,800	—	n/a (No price was disclosed in the filing)		SEC
COVANCE INCListing unverified	Feb 23, 2015	OtherD (derivative)	-2,800	—	n/a (No price was disclosed in the filing)		SEC
COVANCE INCListing unverified	May 22, 2014	Other	-1,505	83.78 USD	$126.1K		SEC
COVANCE INCListing unverified	May 22, 2014	ExerciseD (derivative)	-1,505	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Acurx Pharmaceuticals, Inc.Listing on record	Apr 22, 2026	AwardD (derivative)	2,150	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Acurx Pharmaceuticals, Inc.Listing on record	Jan 8, 2025	Buy	24,631	1.02 USD	$25.1K	conv 73ClusterFirst in 12mo	SEC
Acurx Pharmaceuticals, Inc.Listing on record	Jan 8, 2025	BuyD (derivative)	24,631	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	ClusterFirst in 12mo	SEC
Acurx Pharmaceuticals, Inc.Listing on record	Jun 18, 2024	AwardD (derivative)	12,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Acurx Pharmaceuticals, Inc.Listing on record	Jun 16, 2023	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptiNose, Inc.Listing unverified	Jun 9, 2022	AwardD (derivative)	32,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Acurx Pharmaceuticals, Inc.Listing on record	Jul 6, 2021	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptiNose, Inc.Listing unverified	Jun 10, 2021	AwardD (derivative)	14,439	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptiNose, Inc.Listing unverified	May 11, 2021	Buy	10,000	2.99 USD	$29.9K	conv 44First in 12mo	SEC
OptiNose, Inc.Listing unverified	Jun 12, 2020	AwardD (derivative)	14,439	5.65 USD	$81.6K		SEC
OptiNose, Inc.Listing unverified	Mar 9, 2020	Buy	200	5.53 USD	$1.1K	conv 16Unusual size	SEC
OptiNose, Inc.Listing unverified	Mar 9, 2020	Buy	2,000	5.56 USD	$11.1K	conv 20Unusual size	SEC
OptiNose, Inc.Listing unverified	Mar 9, 2020	Buy	6,500	5.75 USD	$37.4K	conv 34	SEC
OptiNose, Inc.Listing unverified	Dec 9, 2019	Buy	6,100	8.22 USD	$50.1K	conv 54	SEC
OptiNose, Inc.Listing unverified	Jun 10, 2019	AwardD (derivative)	14,439	6.60 USD	$95.3K		SEC
OptiNose, Inc.Listing unverified	Dec 12, 2018	Buy	6,430	7.89 USD	$50.7K	conv 48First in 12mo	SEC
OptiNose, Inc.Listing unverified	Jun 11, 2018	AwardD (derivative)	14,439	22.50 USD	$324.9K		SEC
OptiNose, Inc.Listing unverified	Oct 16, 2017	AwardD (derivative)	43,318	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
COVANCE INCListing unverified	Feb 23, 2015	Other	-7,466	—	n/a (No price was disclosed in the filing)		SEC
COVANCE INCListing unverified	Feb 23, 2015	OtherD (derivative)	-2,800	—	n/a (No price was disclosed in the filing)		SEC
COVANCE INCListing unverified	Feb 23, 2015	OtherD (derivative)	-1,700	—	n/a (No price was disclosed in the filing)		SEC
COVANCE INCListing unverified	Feb 23, 2015	OtherD (derivative)	-2,800	—	n/a (No price was disclosed in the filing)		SEC
COVANCE INCListing unverified	Feb 23, 2015	OtherD (derivative)	-2,800	—	n/a (No price was disclosed in the filing)		SEC
COVANCE INCListing unverified	May 22, 2014	Other	-1,505	83.78 USD	$126.1K		SEC
COVANCE INCListing unverified	May 22, 2014	ExerciseD (derivative)	-1,505	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC